QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Correction to: The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer 期刊论文 Journal of Experimental & Clinical Cancer Research, 2021, 卷号: 40 作者:  Ma,Liying;  Bian,Xing;  Lin,Wenchu 收藏  |  浏览/下载：34/0  |  提交时间：2021/11/29 The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer 期刊论文 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 卷号: 39 作者:  Ma, Liying;  Bian, Xing;  Lin, Wenchu 收藏  |  浏览/下载：38/0  |  提交时间：2020/11/30 SCLC  PI3K  HDAC  CUDC-907  PARP1  Olaparib  DSB repair  Combination treatment   cudc907displayspotentantitumoractivityagainsthumanpancreaticadenocarcinomainvitroandinvivothroughinhibitionofhdac6todownregulatecmycexpression 期刊论文 actapharmacologicasinica, 2019, 卷号: 40, 期号: 5, 页码: 677 作者:  Fu Xuhong;  Zhang Xiong;  Yang Hong;  Xu Xiaowei;  Hu Zonglong 收藏  |  浏览/下载：48/0  |  提交时间：2020/07/01 CANCER  GROWTH  TARGET  PI3K  ACTIVATION   CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression 期刊论文 Acta pharmacologica Sinica, 2018 作者:  Fu, Xu-Hong;  Zhang, Xiong;  Yang, Hong;  Xu, Xiao-Wei;  Hu, Zong-Long 收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08 Novel Therapy for FLT3-ITD Acute Myeloid Leukemia Utilizing the Combination of CUDC-907 and Gilteritinib 期刊论文 BLOOD, 2018, 卷号: 132 作者:  Knight, Tristan;  Qiao, Xinan;  Edwards, Holly;  Lin, Hai;  Taub, Jeffrey W. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Combination of Venetoclax and CUDC-907 Shows Superior Antileukemic Activity Against Acute Myeloid Leukemia Ex Vivo 期刊论文 BLOOD, 2016, 卷号: 128, 期号: 22 作者:  Lin, Hai;  Li, Xinyu;  Ma, Jun;  Su, Yongwei;  Zhao, Jianyun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05